Integrin αvβ5 is a primary receptor for adenovirus in CAR-negative cells

Virology Journal

Volumn 7, Issue , 2010, Pages

  Lyle, Cynthia ^a   McCormick, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA5 INTEGRIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; VIRUS RECEPTOR; VITRONECTIN RECEPTOR;

ADENOVIRUS; ADENOVIRUS INFECTION; ANIMAL CELL; ARTICLE; CELL SURFACE; NONHUMAN; VIRUS ATTACHMENT; VIRUS ENTRY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

ADENOVIRIDAE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; CELL LINE, TUMOR; HUMANS; PROTEIN BINDING; RECEPTORS, VIRUS; RECEPTORS, VITRONECTIN; VIRUS INTERNALIZATION;

EID: 77955020560     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-148     Document Type: Article

References (68)

1. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. PJ Maddon AG Dalgleish JS McDougal PR Clapham RA Weiss R Axel, Cell 1986 47 333 348 10.1016/0092-8674(86)90590-8 3094962
2. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. AG Dalgleish PC Beverley PR Clapham DH Crawford MF Greaves RA Weiss, Nature 1984 312 763 767 10.1038/312763a0 6096719
3. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. H Choe M Farzan Y Sun N Sullivan B Rollins PD Ponath L Wu CR Mackay G LaRosa W Newman,, et al. Cell 1996 85 1135 1148 10.1016/S0092-8674(00)81313-6 8674119
4. Identification of a major co-receptor for primary isolates of HIV-1. H Deng R Liu W Ellmeier S Choe D Unutmaz M Burkhart P Di Marzio S Marmon RE Sutton CM Hill,, et al. Nature 1996 381 661 666 10.1038/381661a0 8649511
5. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. T Dragic V Litwin GP Allaway SR Martin Y Huang KA Nagashima C Cayanan PJ Maddon RA Koup JP Moore WA Paxton, Nature 1996 381 667 673 10.1038/381667a0 8649512
6. An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence. BM Taylor JS Foulke R Flinko A Heredia A DeVico M Reitz, J Virol 2008 82 5460 5471 10.1128/JVI.01049-07 18353949
7. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. PL Jones T Korte R Blumenthal, J Biol Chem 1998 273 404 409 10.1074/jbc.273.1.404 9417096
8. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. TJ Wickham P Mathias DA Cheresh GR Nemerow, Cell 1993 73 309 319 10.1016/0092-8674(93)90231-E 8477447
9. Adenoviruses: update on structure and function. WC Russell, J Gen Virol 2009 90 1 20 10.1099/vir.0.003087-0 19088268
10. Adenovirus receptors. Y Zhang JM Bergelson, J Virol 2005 79 12125 12131 10.1128/JVI.79.19.12125-12131.2005 16160140
11. Virus Taxonomy; Seventh Report of the International Committee of Viruses. CM Fauquet MA Mayo J Maniloff U Desselberger LA Ball, San Diego: Academic Press 2005
12. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. JM Bergelson JA Cunningham G Droguett EA Kurt-Jones A Krithivas JS Hong MS Horwitz RL Crowell RW Finberg, Science 1997 275 1320 1323 10.1126/science.275.5304.1320 9036860
13. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. S Huang T Kamata Y Takada ZM Ruggeri GR Nemerow, J Virol 1996 70 4502 4508 8676475
14. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. MC Dechecchi P Melotti A Bonizzato M Santacatterina M Chilosi G Cabrini, J Virol 2001 75 8772 8780 10.1128/JVI.75.18.8772-8780.2001 11507222
15. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. MC Dechecchi A Tamanini A Bonizzato G Cabrini, Virology 2000 268 382 390 10.1006/viro.1999.0171 10704346
16. Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. WC Adams E Bond MJ Havenga L Holterman J Goudsmit GB Karlsson Hedestam RA Koup K Lore, J Gen Virol 2009 90 1600 1610 10.1099/vir.0.008342-0 19282435
17. Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. C Johansson M Jonsson M Marttila D Persson XL Fan J Skog L Frangsmyr G Wadell N Arnberg, J Virol 2007 81 954 963 10.1128/JVI.01995-06 17079302
18. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. R Alemany DT Curiel, Gene Ther 2001 8 1347 1353 10.1038/sj.gt.3301515 11571572
19. Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. AL Parker JH McVey JH Doctor O Lopez-Franco SN Waddington MJ Havenga SA Nicklin AH Baker, J Virol 2007 81 3627 3631 10.1128/JVI.02786-06 17251290
20. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. DM Shayakhmetov A Gaggar S Ni ZY Li A Lieber, J Virol 2005 79 7478 7491 10.1128/JVI.79.12.7478-7491.2005 15919903
21. Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. TA Smith N Idamakanti J Marshall-Neff ML Rollence P Wright M Kaloss L King C Mech L Dinges WO Iverson,, et al. Hum Gene Ther 2003 14 1595 1604 10.1089/104303403322542248 14633402
22. Adenovirus serotype 5 hexon mediates liver gene transfer. SN Waddington JH McVey D Bhella AL Parker K Barker H Atoda R Pink SM Buckley JA Greig L Denby,, et al. Cell 2008 132 397 409 10.1016/j.cell.2008.01.016 18267072
23. Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. SN Waddington AL Parker M Havenga SA Nicklin SM Buckley JH McVey AH Baker, J Virol 2007 81 9568 9571 10.1128/JVI.00663-07 17553882
24. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. AL Parker SN Waddington CG Nicol DM Shayakhmetov SM Buckley L Denby G Kemball-Cook S Ni A Lieber JH McVey,, et al. Blood 2006 108 2554 2561 10.1182/blood-2006-04-008532 16788098
25. Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions. DA Einfeld R Schroeder PW Roelvink A Lizonova CR King I Kovesdi TJ Wickham, J Virol 2001 75 11284 11291 10.1128/JVI.75.23.11284-11291.2001 11689608
26. Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. P Leissner V Legrand Y Schlesinger DA Hadji M van Raaij S Cusack A Pavirani M Mehtali, Gene Ther 2001 8 49 57 10.1038/sj.gt.3301343 11402301
27. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells. M Candolfi JF Curtin WD Xiong KM Kroeger C Liu A Rentsendorj H Agadjanian L Medina-Kauwe D Palmer P Ng,, et al. Mol Ther 2006 14 371 381 10.1016/j.ymthe.2006.05.006 16798098
28. Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression. A Sabichi A Keyhani N Tanaka J Delacerda IL Lee C Zou JH Zhou WF Benedict HB Grossman, J Urol 2006 175 1133 1137 10.1016/S0022-5347(05)00323-X 16469639
29. Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. M Anders M Vieth C Rocken M Ebert M Pross S Gretschel PM Schlag B Wiedenmann W Kemmner M Hocker, Br J Cancer 2009 100 352 359 10.1038/sj.bjc.6604876 19142187
30. Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients. YS Jee SG Lee JC Lee MJ Kim JJ Lee DY Kim SW Park MW Sung DS Heo, Anticancer Res 2002 22 2629 2634 12529974
31. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Y Li RC Pong JM Bergelson MC Hall AI Sagalowsky CP Tseng Z Wang JT Hsieh, Cancer Res 1999 59 325 330 9927041
32. Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. K Matsumoto SF Shariat GE Ayala KA Rauen SP Lerner, Urology 2005 66 441 446 10.1016/j.urology.2005.02.033 16040097
33. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. T Okegawa Y Li RC Pong JM Bergelson J Zhou JT Hsieh, Cancer Res 2000 60 5031 5036 11016624
34. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. KA Rauen D Sudilovsky JL Le KL Chew B Hann V Weinberg LD Schmitt F McCormick, Cancer Res 2002 62 3812 3818 12097294
35. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. M Anders C Christian M McMahon F McCormick WM Korn, Cancer Res 2003 63 2088 2095 12727824
36. Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. M Anders R Hansen RX Ding KA Rauen MJ Bissell WM Korn, Proc Natl Acad Sci USA 2003 100 1943 1948 10.1073/pnas.0337599100 12576544
37. Virus-receptor interaction in an adenovirus system. L Philipson K Lonberg-Holm U Pettersson, J Virol 1968 2 1064 1075 5723709
38. Integrins: versatility, modulation, and signaling in cell adhesion. RO Hynes, Cell 1992 69 11 25 10.1016/0092-8674(92)90115-S 1555235
39. Cell integrins: commonly used receptors for diverse viral pathogens. PL Stewart GR Nemerow, Trends Microbiol 2007 15 500 507 10.1016/j.tim.2007.10.001 17988871
40. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. AL Feire H Koss T Compton, Proc Natl Acad Sci USA 2004 101 15470 15475 10.1073/pnas.0406821101 15494436
41. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. IN Gavrilovskaya M Shepley R Shaw MH Ginsberg ER Mackow, Proc Natl Acad Sci USA 1998 95 7074 7079 10.1073/pnas.95.12.7074 9618541
42. Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells. MJ Hewish Y Takada BS Coulson, J Virol 2000 74 228 236 10.1128/JVI.74.1.228-236.2000 10590110
43. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. S Miyamoto SK Akiyama KM Yamada, Science 1995 267 883 885 10.1126/science.7846531 7846531
44. Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin. CY Chiu P Mathias GR Nemerow PL Stewart, J Virol 1999 73 6759 6768 10400774
45. Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. B Salone Y Martina S Piersanti E Cundari G Cherubini L Franqueville CM Failla P Boulanger I Saggio, J Virol 2003 77 13448 13454 10.1128/JVI.77.24. 13448-13454.2003 14645603
46. Integrin ligands at a glance. JD Humphries A Byron MJ Humphries, J Cell Sci 2006 119 3901 3903 10.1242/jcs.03098 16988024
47. Integrin alpha(v)beta1 is an adenovirus coreceptor. E Li SL Brown DG Stupack XS Puente DA Cheresh GR Nemerow, J Virol 2001 75 5405 5409 10.1128/JVI.75.11.5405-5409.2001 11333925
48. Fundamentals of Receptor, Enzyme, and Transport Kinetics. JC Mathews, Boca Raton: CRC Press 1993
49. Chemokine antagonists as therapeutics: focus on HIV-1. AM Tsibris DR Kuritzkes, Annu Rev Med 2007 58 445 459 10.1146/annurev.med.58.080105.102908 16958560
50. CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo. J Bhattacharya PJ Peters PR Clapham, Aids 2003 17 Suppl 4 35 43 10.1097/00002030-200317004-00004 15080178
51. What does it take to bind CAR? LK Law BL Davidson, Mol Ther 2005 12 599 609 10.1016/j.ymthe.2005.05.017 16109509
52. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. X Wang JM Bergelson, J Virol 1999 73 2559 2562 9971843
53. Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions. H Lortat-Jacob E Chouin S Cusack MJ van Raaij, J Biol Chem 2001 276 9009 9015 10.1074/jbc.M009304200 11124261
54. Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. RW Walters P Freimuth TO Moninger I Ganske J Zabner MJ Welsh, Cell 2002 110 789 799 10.1016/S0092-8674(02)00912-1 12297051
55. Coxsackie adenovirus receptor (CAR) regulates integrin function through activation of p44/42 MAPK. C Farmer PE Morton M Snippe G Santis M Parsons, Exp Cell Res 2009 315 2637 2647 10.1016/j.yexcr.2009.06.008 19527712
56. Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment. PW Roelvink I Kovesdi TJ Wickham, J Virol 1996 70 7614 7621 8892881
57. Multistep entry of rotavirus into cells: a Versaillesque dance. S Lopez CF Arias, Trends Microbiol 2004 12 271 278 10.1016/j.tim.2004.04.003 15165605
58. Identification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection. JE Ludert BB Mason J Angel B Tang Y Hoshino N Feng PT Vo EM Mackow FM Ruggeri HB Greenberg, J Gen Virol 1998 79 Pt 4 725 729 9568967
59. Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. E Mendez CF Arias S Lopez, J Virol 1993 67 5253 5259 8394448
60. Gene therapy clinical trials worldwide 1989-2004-an overview. ML Edelstein MR Abedi J Wixon RM Edelstein, J Gene Med 2004 6 597 602 10.1002/jgm.619 15170730
61. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. MV Carriero S Del Vecchio M Capozzoli P Franco L Fontana A Zannetti G Botti G D'Aiuto M Salvatore MP Stoppelli, Cancer Res 1999 59 5307 5314 10537314
62. Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid- differentiated neuroblastoma cells. CL Gladson C Dennis TC Rotolo DR Kelly JR Grammer, Am J Pathol 1997 150 1631 1646 9137089
63. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. RC Carlisle Y Di AM Cerny AF Sonnen RB Sim NK Green V Subr K Ulbrich RJ Gilbert KD Fisher,, et al. Blood 2009 113 1909 1918 10.1182/blood-2008-09-178459 19131551
64. The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. E Seiradake D Henaff H Wodrich O Billet M Perreau C Hippert F Mennechet G Schoehn H Lortat-Jacob H Dreja,, et al. PLoS Pathog 2009 5 1000277 10.1371/journal.ppat.1000277 19119424
65. CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. Y Wang R Gangeswaran X Zhao P Wang J Tysome V Bhakta M Yuan CP Chikkanna-Gowda G Jiang D Gao,, et al. J Clin Invest 2009 119 1604 1615 10.1172/JCI37905 19411761
66. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. V Krougliak FL Graham, Hum Gene Ther 1995 6 1575 1586 10.1089/hum.1995.6.12-1575 8664382
67. Preparation and titration of CsCl-banded adenovirus stock. AE Tollefson TW Hermiston WSM Wold, Methods in Molecular Medicine 1998 20 1
68. Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents. L Johnson A Shen L Boyle J Kunich K Pandey M Lemmon T Hermiston M Giedlin F McCormick A Fattaey, Cancer Cell 2002 1 325 337 10.1016/S1535-6108(02)00060-0 12086848